Mark S. Gelder

689 total citations
16 papers, 507 citations indexed

About

Mark S. Gelder is a scholar working on Surgery, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Mark S. Gelder has authored 16 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Reproductive Medicine and 6 papers in Obstetrics and Gynecology. Recurrent topics in Mark S. Gelder's work include Ovarian cancer diagnosis and treatment (7 papers), Intraperitoneal and Appendiceal Malignancies (4 papers) and Uterine Myomas and Treatments (3 papers). Mark S. Gelder is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Intraperitoneal and Appendiceal Malignancies (4 papers) and Uterine Myomas and Treatments (3 papers). Mark S. Gelder collaborates with scholars based in United States. Mark S. Gelder's co-authors include Vicki V. Baker, Kenneth D. Hatch, Hugh M. Shingleton, Linda S. Morgan, Anil K. Sood, Seng‐Jaw Soong, J Bénda, Richard E. Buller, Joel I. Sorosky and Edward J. Wilkinson and has published in prestigious journals such as Cancer, American Journal of Obstetrics and Gynecology and Fertility and Sterility.

In The Last Decade

Mark S. Gelder

16 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark S. Gelder United States 10 286 230 186 141 131 16 507
Heinz Scholz Austria 14 232 0.8× 123 0.5× 173 0.9× 114 0.8× 70 0.5× 22 438
G Michel France 11 439 1.5× 292 1.3× 395 2.1× 128 0.9× 92 0.7× 36 748
J M Childers United States 6 157 0.5× 151 0.7× 128 0.7× 63 0.4× 76 0.6× 8 340
Maria B. Schiavone United States 10 290 1.0× 219 1.0× 284 1.5× 99 0.7× 49 0.4× 23 538
William J. Hoskins United States 8 294 1.0× 249 1.1× 300 1.6× 89 0.6× 171 1.3× 8 565
Francis C. Grumbine United States 14 464 1.6× 268 1.2× 314 1.7× 87 0.6× 41 0.3× 22 700
Pedro T. Ramirez United States 13 396 1.4× 186 0.8× 203 1.1× 102 0.7× 63 0.5× 24 549
Sanford Sall United States 14 293 1.0× 124 0.5× 148 0.8× 88 0.6× 32 0.2× 33 537
Turgut Alkıbay Türkiye 13 86 0.3× 239 1.0× 74 0.4× 36 0.3× 250 1.9× 36 540
Mauro P. Gangai United States 12 67 0.2× 191 0.8× 32 0.2× 76 0.5× 175 1.3× 20 464

Countries citing papers authored by Mark S. Gelder

Since Specialization
Citations

This map shows the geographic impact of Mark S. Gelder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Gelder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Gelder more than expected).

Fields of papers citing papers by Mark S. Gelder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Gelder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Gelder. The network helps show where Mark S. Gelder may publish in the future.

Co-authorship network of co-authors of Mark S. Gelder

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Gelder. A scholar is included among the top collaborators of Mark S. Gelder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Gelder. Mark S. Gelder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sood, Anil K., Joel I. Sorosky, Mark S. Gelder, et al.. (1998). Primary ovarian sarcoma. Cancer. 82(9). 1731–1737. 64 indexed citations
2.
Irvin, William P., Fredric V. Price, Howard H. Bailey, et al.. (1998). A phase II study of irinotecan (CPT‐11) in patients with advanced squamous cell carcinoma of the cervix. Cancer. 82(2). 328–333. 34 indexed citations
3.
Sood, Anil K., Joel I. Sorosky, Mark S. Gelder, et al.. (1998). Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction.. PubMed. 82(9). 1731–7. 91 indexed citations
4.
Sood, Anil K., Joel I. Sorosky, Mark S. Gelder, et al.. (1998). Primary ovarian sarcoma. Cancer. 82(9). 1731–1737. 1 indexed citations
5.
Gelder, Mark S.. (1995). Life and death decisions in the intensive care unit. Cancer. 76(S10). 2171–2175. 9 indexed citations
6.
Gelder, Mark S., et al.. (1995). Massive Edema of the Ovary Associated With Androgenic Manifestations. Southern Medical Journal. 88(11). 1153–1155. 4 indexed citations
7.
Sood, Anil K., et al.. (1995). Anaphylaxis to Carboplatin Following Multiple Previous Uncomplicated Courses. Gynecologic Oncology. 57(1). 131–132. 30 indexed citations
8.
Partridge, Edward E., Mark S. Gelder, Ronald D. Alvarez, et al.. (1993). The Validity and Significance of Substages of Advanced Ovarian Cancer. Gynecologic Oncology. 48(2). 236–241. 7 indexed citations
9.
Gelder, Mark S., Ronald D. Alvarez, & Edward E. Partridge. (1993). Ureteroarterial Fistulae in Exenteration Patients with Indwelling Ureteral Stents. Gynecologic Oncology. 50(3). 365–370. 21 indexed citations
10.
Alvarez, Ronald D., et al.. (1993). Radical hysterectomy in the treatment of patients with bulky early stage carcinoma of the cervix uteri.. PubMed. 176(6). 539–42. 11 indexed citations
11.
Gelder, Mark S., et al.. (1992). The validity and significance of substages in advanced ovarian carcinoma. Gynecologic Oncology. 45(1). 78–78. 1 indexed citations
12.
Gelder, Mark S., Larry R. Boots, & J. Benjamin Younger. (1991). Use of a single random serum progesterone value as a diagnostic aid for ectopic pregnancy. Fertility and Sterility. 55(3). 497–500. 38 indexed citations
13.
Hatch, Kenneth D., Mark S. Gelder, Seng-Jaw Soong, Vicki V. Baker, & Hugh M. Shingleton. (1990). Pelvic exenteration with low rectal anastomosis: Survival, complications, and prognostic factors. Gynecologic Oncology. 38(3). 462–467. 47 indexed citations
14.
Shingleton, Hugh M., et al.. (1989). Clinical and Histopathologic Factors Predicting Recurrence and Survival After Pelvic Exenteration for Cancer of the Cervix. American Journal of Obstetrics and Gynecology. 73(6). 1027–1034. 127 indexed citations
15.
Gelder, Mark S., et al.. (1988). Anterior pelvic exenteration. Gynecologic Oncology. 29(1). 128–128. 1 indexed citations
16.
Hatch, Kenneth D., Hugh M. Shingleton, Seng-Jaw Soong, Vicki V. Baker, & Mark S. Gelder. (1988). Anterior pelvic exenteration. Gynecologic Oncology. 31(1). 205–213. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026